Effectiveness of a self-management intervention on clinical outcomes among patients with type 2 diabetes at high risk for Diabetic Kidney Disease: A Randomised Controlled Trial.

In 30 seconds

This prospective, two-arm randomised controlled trial at a tertiary hospital in China evaluated a structured self-management programme in 134 adults with type 2 diabetes classified as at high risk of diabetic kidney disease. Participants received either the 12-week programme or usual care, with outcomes assessed through 24 weeks. Compared with usual care, the intervention group had significant improvements in HbA1c, estimated glomerular filtration rate, systolic blood pressure and LDL cholesterol. Urinary albumin-to-creatinine ratio, BMI and waist circumference did not differ significantly between groups. The abstract does not report effect sizes for these outcomes.

Key findings

• Compared with usual care, the intervention significantly improved HbA1c, eGFR, systolic blood pressure and LDL-C.
• No significant between-group differences were found for UACR, BMI or waist circumference.
• The trial randomised 134 participants; 7 intervention and 9 control participants were lost to follow-up at T1.

Why it matters

The findings suggest that structured self-management may improve several clinical risk factors in people with type 2 diabetes identified as being at high risk of kidney disease. This is relevant to early prevention because the study focused on a higher-risk population before later-stage disease. However, the abstract reports no effect sizes and does not establish whether the observed changes prevent kidney disease progression or improve longer-term outcomes.

What to keep in mind

The trial was conducted at a single tertiary hospital, and follow-up extended only to 24 weeks. The abstract does not provide effect sizes for the significant outcomes.